List of Tables
    Table 1. Immunosuppressant for Systemic Lupus Erythematosus Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Immunosuppressant for Systemic Lupus Erythematosus Market Trends
    Table 3. Immunosuppressant for Systemic Lupus Erythematosus Market Drivers
    Table 4. Immunosuppressant for Systemic Lupus Erythematosus Market Challenges
    Table 5. Immunosuppressant for Systemic Lupus Erythematosus Market Restraints
    Table 6. Global Immunosuppressant for Systemic Lupus Erythematosus Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Immunosuppressant for Systemic Lupus Erythematosus Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Immunosuppressant for Systemic Lupus Erythematosus Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Immunosuppressant for Systemic Lupus Erythematosus Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Immunosuppressant for Systemic Lupus Erythematosus Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Immunosuppressant for Systemic Lupus Erythematosus Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Immunosuppressant for Systemic Lupus Erythematosus Revenue Share by Player, 2017-2022
    Table 13. Global Immunosuppressant for Systemic Lupus Erythematosus Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Immunosuppressant for Systemic Lupus Erythematosus by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunosuppressant for Systemic Lupus Erythematosus as of 2021)
    Table 15. Top Players of Immunosuppressant for Systemic Lupus Erythematosus in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Immunosuppressant for Systemic Lupus Erythematosus Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Immunosuppressant for Systemic Lupus Erythematosus Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Immunosuppressant for Systemic Lupus Erythematosus Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Immunosuppressant for Systemic Lupus Erythematosus Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Immunosuppressant for Systemic Lupus Erythematosus Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Immunosuppressant for Systemic Lupus Erythematosus Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Immunosuppressant for Systemic Lupus Erythematosus Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Immunosuppressant for Systemic Lupus Erythematosus Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Immunosuppressant for Systemic Lupus Erythematosus Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Immunosuppressant for Systemic Lupus Erythematosus Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Immunosuppressant for Systemic Lupus Erythematosus Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Immunosuppressant for Systemic Lupus Erythematosus Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Alcon Company Details
    Table 31. Alcon Business Overview
    Table 32. Alcon Immunosuppressant for Systemic Lupus Erythematosus Product
    Table 33. Alcon Revenue in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022) & (US$ Million)
    Table 34. Alcon Recent Development
    Table 35. Alkem Laboratories Company Details
    Table 36. Alkem Laboratories Business Overview
    Table 37. Alkem Laboratories Immunosuppressant for Systemic Lupus Erythematosus Product
    Table 38. Alkem Laboratories Revenue in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022) & (US$ Million)
    Table 39. Alkem Laboratories Recent Development
    Table 40. Allergan Company Details
    Table 41. Allergan Business Overview
    Table 42. Allergan Immunosuppressant for Systemic Lupus Erythematosus Product
    Table 43. Allergan Revenue in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022) & (US$ Million)
    Table 44. Allergan Recent Development
    Table 45. Amneal Pharmaceuticals Company Details
    Table 46. Amneal Pharmaceuticals Business Overview
    Table 47. Amneal Pharmaceuticals Immunosuppressant for Systemic Lupus Erythematosus Product
    Table 48. Amneal Pharmaceuticals Revenue in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022) & (US$ Million)
    Table 49. Amneal Pharmaceuticals Recent Development
    Table 50. Astellas Pharma Company Details
    Table 51. Astellas Pharma Business Overview
    Table 52. Astellas Pharma Immunosuppressant for Systemic Lupus Erythematosus Product
    Table 53. Astellas Pharma Revenue in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022) & (US$ Million)
    Table 54. Astellas Pharma Recent Development
    Table 55. Baxter Company Details
    Table 56. Baxter Business Overview
    Table 57. Baxter Immunosuppressant for Systemic Lupus Erythematosus Product
    Table 58. Baxter Revenue in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022) & (US$ Million)
    Table 59. Baxter Recent Development
    Table 60. Beijing Jialin Pharmaceutical Company Details
    Table 61. Beijing Jialin Pharmaceutical Business Overview
    Table 62. Beijing Jialin Pharmaceutical Immunosuppressant for Systemic Lupus Erythematosus Product
    Table 63. Beijing Jialin Pharmaceutical Revenue in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022) & (US$ Million)
    Table 64. Beijing Jialin Pharmaceutical Recent Development
    Table 65. Genentech Company Details
    Table 66. Genentech Business Overview
    Table 67. Genentech Immunosuppressant for Systemic Lupus Erythematosus Product
    Table 68. Genentech Revenue in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022) & (US$ Million)
    Table 69. Genentech Recent Development
    Table 70. Jubilant Cadista Company Details
    Table 71. Jubilant Cadista Business Overview
    Table 72. Jubilant Cadista Immunosuppressant for Systemic Lupus Erythematosus Product
    Table 73. Jubilant Cadista Revenue in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022) & (US$ Million)
    Table 74. Jubilant Cadista Recent Development
    Table 75. LGM Pharma Company Details
    Table 76. LGM Pharma Business Overview
    Table 77. LGM Pharma Immunosuppressant for Systemic Lupus Erythematosus Product
    Table 78. LGM Pharma Revenue in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022) & (US$ Million)
    Table 79. LGM Pharma Recent Development
    Table 80. LingNan Pharmaceutical Company Details
    Table 81. LingNan Pharmaceutical Business Overview
    Table 82. LingNan Pharmaceutical Immunosuppressant for Systemic Lupus Erythematosus Product
    Table 83. LingNan Pharmaceutical Revenue in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022) & (US$ Million)
    Table 84. LingNan Pharmaceutical Recent Development
    Table 85. Merck Company Details
    Table 86. Merck Business Overview
    Table 87. Merck Immunosuppressant for Systemic Lupus Erythematosus Product
    Table 88. Merck Revenue in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022) & (US$ Million)
    Table 89. Merck Recent Development
    Table 90. Mimetogen Pharmaceuticals Company Details
    Table 91. Mimetogen Pharmaceuticals Business Overview
    Table 92. Mimetogen Pharmaceuticals Immunosuppressant for Systemic Lupus Erythematosus Product
    Table 93. Mimetogen Pharmaceuticals Revenue in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022) & (US$ Million)
    Table 94. Mimetogen Pharmaceuticals Recent Development
    Table 95. Mylan Company Details
    Table 96. Mylan Business Overview
    Table 97. Mylan Immunosuppressant for Systemic Lupus Erythematosus Product
    Table 98. Mylan Revenue in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022) & (US$ Million)
    Table 99. Mylan Recent Development
    Table 100. Otsuka Pharmaceutical Company Details
    Table 101. Otsuka Pharmaceutical Business Overview
    Table 102. Otsuka Pharmaceutical Immunosuppressant for Systemic Lupus Erythematosus Product
    Table 103. Otsuka Pharmaceutical Revenue in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022) & (US$ Million)
    Table 104. Otsuka Pharmaceutical Recent Development
    Table 105. Par Pharmaceutical Company Details
    Table 106. Par Pharmaceutical Business Overview
    Table 107. Par Pharmaceutical Immunosuppressant for Systemic Lupus Erythematosus Product
    Table 108. Par Pharmaceutical Revenue in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022) & (US$ Million)
    Table 109. Par Pharmaceutical Recent Development
    Table 110. Pfizer Company Details
    Table 111. Pfizer Business Overview
    Table 112. Pfizer Immunosuppressant for Systemic Lupus Erythematosus Product
    Table 113. Pfizer Revenue in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022) & (US$ Million)
    Table 114. Pfizer Recent Development
    Table 115. Powerdone Company Details
    Table 116. Powerdone Business Overview
    Table 117. Powerdone Immunosuppressant for Systemic Lupus Erythematosus Product
    Table 118. Powerdone Revenue in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022) & (US$ Million)
    Table 119. Powerdone Recent Development
    Table 120. Regenerx Biopharmaceuticals Company Details
    Table 121. Regenerx Biopharmaceuticals Business Overview
    Table 122. Regenerx Biopharmaceuticals Immunosuppressant for Systemic Lupus Erythematosus Product
    Table 123. Regenerx Biopharmaceuticals Revenue in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022) & (US$ Million)
    Table 124. Regenerx Biopharmaceuticals Recent Development
    Table 125. Roxane Laboratories Company Details
    Table 126. Roxane Laboratories Business Overview
    Table 127. Roxane Laboratories Immunosuppressant for Systemic Lupus Erythematosus Product
    Table 128. Roxane Laboratories Revenue in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022) & (US$ Million)
    Table 129. Roxane Laboratories Recent Development
    Table 130. Sandoz Company Details
    Table 131. Sandoz Business Overview
    Table 132. Sandoz Immunosuppressant for Systemic Lupus Erythematosus Product
    Table 133. Sandoz Revenue in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022) & (US$ Million)
    Table 134. Sandoz Recent Development
    Table 135. Sanofi Company Details
    Table 136. Sanofi Business Overview
    Table 137. Sanofi Immunosuppressant for Systemic Lupus Erythematosus Product
    Table 138. Sanofi Revenue in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022) & (US$ Million)
    Table 139. Sanofi Recent Development
    Table 140. Santen Pharmaceutical Company Details
    Table 141. Santen Pharmaceutical Business Overview
    Table 142. Santen Pharmaceutical Immunosuppressant for Systemic Lupus Erythematosus Product
    Table 143. Santen Pharmaceutical Revenue in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022) & (US$ Million)
    Table 144. Santen Pharmaceutical Recent Development
    Table 145. Takeda Company Details
    Table 146. Takeda Business Overview
    Table 147. Takeda Immunosuppressant for Systemic Lupus Erythematosus Product
    Table 148. Takeda Revenue in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022) & (US$ Million)
    Table 149. Takeda Recent Development
    Table 150. Sine Company Details
    Table 151. Sine Business Overview
    Table 152. Sine Immunosuppressant for Systemic Lupus Erythematosus Product
    Table 153. Sine Revenue in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022) & (US$ Million)
    Table 154. Sine Recent Development
    Table 155. Strides Pharma Company Details
    Table 156. Strides Pharma Business Overview
    Table 157. Strides Pharma Immunosuppressant for Systemic Lupus Erythematosus Product
    Table 158. Strides Pharma Revenue in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022) & (US$ Million)
    Table 159. Strides Pharma Recent Development
    Table 160. Talon Therapeutics Company Details
    Table 161. Talon Therapeutics Business Overview
    Table 162. Talon Therapeutics Immunosuppressant for Systemic Lupus Erythematosus Product
    Table 163. Talon Therapeutics Revenue in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022) & (US$ Million)
    Table 164. Talon Therapeutics Recent Development
    Table 165. Teva Company Details
    Table 166. Teva Business Overview
    Table 167. Teva Immunosuppressant for Systemic Lupus Erythematosus Product
    Table 168. Teva Revenue in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022) & (US$ Million)
    Table 169. Teva Recent Development
    Table 170. United Biotech Company Details
    Table 171. United Biotech Business Overview
    Table 172. United Biotech Immunosuppressant for Systemic Lupus Erythematosus Product
    Table 173. United Biotech Revenue in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022) & (US$ Million)
    Table 174. United Biotech Recent Development
    Table 175. West Ward Pharmaceuticals Company Details
    Table 176. West Ward Pharmaceuticals Business Overview
    Table 177. West Ward Pharmaceuticals Immunosuppressant for Systemic Lupus Erythematosus Product
    Table 178. West Ward Pharmaceuticals Revenue in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022) & (US$ Million)
    Table 179. West Ward Pharmaceuticals Recent Development
    Table 180. Research Programs/Design for This Report
    Table 181. Key Data Information from Secondary Sources
    Table 182. Key Data Information from Primary Sources
List of Figures
    Figure 1. Immunosuppressant for Systemic Lupus Erythematosus Product Picture
    Figure 2. Global Immunosuppressant for Systemic Lupus Erythematosus Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Immunosuppressant for Systemic Lupus Erythematosus Market Size 2017-2028 (US$ Million)
    Figure 4. United States Immunosuppressant for Systemic Lupus Erythematosus Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Immunosuppressant for Systemic Lupus Erythematosus Market Size 2017-2028 (US$ Million)
    Figure 6. United States Immunosuppressant for Systemic Lupus Erythematosus Market Share in Global 2017-2028
    Figure 7. Immunosuppressant for Systemic Lupus Erythematosus Report Years Considered
    Figure 8. Product Picture of Cyclophosphamide
    Figure 9. Product Picture of Mycophenolate Mofetil
    Figure 10. Product Picture of Azathioprine
    Figure 11. Product Picture of Cyclosporine A
    Figure 12. Product Picture of Tacrolimus
    Figure 13. Product Picture of Methotrexate
    Figure 14. Product Picture of Leflunomide
    Figure 15. Product Picture of Vincristine
    Figure 16. Product Picture of Other
    Figure 17. Global Immunosuppressant for Systemic Lupus Erythematosus Market Share by Type in 2022 & 2028
    Figure 18. Global Immunosuppressant for Systemic Lupus Erythematosus Market Size by Type (2017-2028) & (US$ Million)
    Figure 19. Global Immunosuppressant for Systemic Lupus Erythematosus Market Share by Type (2017-2028)
    Figure 20. United States Immunosuppressant for Systemic Lupus Erythematosus Market Share by Type in 2022 & 2028
    Figure 21. United States Immunosuppressant for Systemic Lupus Erythematosus Market Size by Type (2017-2028) & (US$ Million)
    Figure 22. United States Immunosuppressant for Systemic Lupus Erythematosus Market Share by Type (2017-2028)
    Figure 23. Product Picture of Hospital
    Figure 24. Product Picture of Clinic
    Figure 25. Product Picture of Pharmacy
    Figure 26. Product Picture of Other
    Figure 27. Global Immunosuppressant for Systemic Lupus Erythematosus Market Share by Application in 2022 & 2028
    Figure 28. Global Immunosuppressant for Systemic Lupus Erythematosus Market Size by Application (2017-2028) & (US$ Million)
    Figure 29. Global Immunosuppressant for Systemic Lupus Erythematosus Market Share by Application (2017-2028)
    Figure 30. United States Immunosuppressant for Systemic Lupus Erythematosus Market Share by Application in 2022 & 2028
    Figure 31. United States Immunosuppressant for Systemic Lupus Erythematosus Market Size by Application (2017-2028) & (US$ Million)
    Figure 32. United States Immunosuppressant for Systemic Lupus Erythematosus Market Share by Application (2017-2028)
    Figure 33. North America Immunosuppressant for Systemic Lupus Erythematosus Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 34. U.S. Immunosuppressant for Systemic Lupus Erythematosus Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Canada Immunosuppressant for Systemic Lupus Erythematosus Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Europe Immunosuppressant for Systemic Lupus Erythematosus Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 37. Germany Immunosuppressant for Systemic Lupus Erythematosus Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. France Immunosuppressant for Systemic Lupus Erythematosus Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. U.K. Immunosuppressant for Systemic Lupus Erythematosus Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Italy Immunosuppressant for Systemic Lupus Erythematosus Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Russia Immunosuppressant for Systemic Lupus Erythematosus Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Asia-Pacific Immunosuppressant for Systemic Lupus Erythematosus Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 43. China Immunosuppressant for Systemic Lupus Erythematosus Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Japan Immunosuppressant for Systemic Lupus Erythematosus Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. South Korea Immunosuppressant for Systemic Lupus Erythematosus Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. India Immunosuppressant for Systemic Lupus Erythematosus Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Australia Immunosuppressant for Systemic Lupus Erythematosus Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Taiwan Immunosuppressant for Systemic Lupus Erythematosus Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Indonesia Immunosuppressant for Systemic Lupus Erythematosus Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Thailand Immunosuppressant for Systemic Lupus Erythematosus Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Malaysia Immunosuppressant for Systemic Lupus Erythematosus Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Philippines Immunosuppressant for Systemic Lupus Erythematosus Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Latin America Immunosuppressant for Systemic Lupus Erythematosus Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 54. Mexico Immunosuppressant for Systemic Lupus Erythematosus Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Brazil Immunosuppressant for Systemic Lupus Erythematosus Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Argentina Immunosuppressant for Systemic Lupus Erythematosus Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Middle East & Africa Immunosuppressant for Systemic Lupus Erythematosus Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 58. Turkey Immunosuppressant for Systemic Lupus Erythematosus Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Saudi Arabia Immunosuppressant for Systemic Lupus Erythematosus Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 60. U.A.E Immunosuppressant for Systemic Lupus Erythematosus Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Alcon Revenue Growth Rate in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022)
    Figure 62. Alkem Laboratories Revenue Growth Rate in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022)
    Figure 63. Allergan Revenue Growth Rate in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022)
    Figure 64. Amneal Pharmaceuticals Revenue Growth Rate in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022)
    Figure 65. Astellas Pharma Revenue Growth Rate in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022)
    Figure 66. Baxter Revenue Growth Rate in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022)
    Figure 67. Beijing Jialin Pharmaceutical Revenue Growth Rate in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022)
    Figure 68. Genentech Revenue Growth Rate in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022)
    Figure 69. Jubilant Cadista Revenue Growth Rate in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022)
    Figure 70. LGM Pharma Revenue Growth Rate in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022)
    Figure 71. LingNan Pharmaceutical Revenue Growth Rate in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022)
    Figure 72. Merck Revenue Growth Rate in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022)
    Figure 73. Mimetogen Pharmaceuticals Revenue Growth Rate in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022)
    Figure 74. Mylan Revenue Growth Rate in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022)
    Figure 75. Otsuka Pharmaceutical Revenue Growth Rate in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022)
    Figure 76. Par Pharmaceutical Revenue Growth Rate in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022)
    Figure 77. Pfizer Revenue Growth Rate in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022)
    Figure 78. Powerdone Revenue Growth Rate in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022)
    Figure 79. Regenerx Biopharmaceuticals Revenue Growth Rate in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022)
    Figure 80. Roxane Laboratories Revenue Growth Rate in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022)
    Figure 81. Sandoz Revenue Growth Rate in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022)
    Figure 82. Sanofi Revenue Growth Rate in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022)
    Figure 83. Santen Pharmaceutical Revenue Growth Rate in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022)
    Figure 84. Takeda Revenue Growth Rate in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022)
    Figure 85. Sine Revenue Growth Rate in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022)
    Figure 86. Strides Pharma Revenue Growth Rate in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022)
    Figure 87. Talon Therapeutics Revenue Growth Rate in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022)
    Figure 88. Teva Revenue Growth Rate in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022)
    Figure 89. United Biotech Revenue Growth Rate in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022)
    Figure 90. West Ward Pharmaceuticals Revenue Growth Rate in Immunosuppressant for Systemic Lupus Erythematosus Business (2017-2022)
    Figure 91. Bottom-up and Top-down Approaches for This Report
    Figure 92. Data Triangulation
    Figure 93. Key Executives Interviewed